A practical reference on lyophilisation: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-01-29. Anything still debated is marked as such rather than presented as settled.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
| Property | Value | Notes |
|---|---|---|
| Name type | Commercial trade name | Not a systematic chemical identifier |
| Parent peptide | Thymosin beta-4 | 43-residue natural peptide |
| Common fragment sequence | LKKTETQ | Maps to part of the actin-binding region |
| Molecular size class | Roughly 0.8-1.0 kDa | Depends on exact fragment and terminal modification |
| Regulatory status | Prohibited in sport | Grouped with peptide hormones in many frameworks |
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
On 18 September, Donald Trump posted on Truth Social that the US, Denmark, and Greenland had agreed to a new security deal that addressed all of the US's concerns, and provided for a larger US military footprint. Trump claimed that the deal gives the US "permanent control" over security in Greenland, while officials from Denmark and Greenland said that the deal does not transfer sovereignty of Greenland to the US. Trump also said that his administration would begin cooperating with local authorities to maintain a "large Military presence in the appropriate part of Greenland, of which there are many." An anonymous State Department official said the deal would remain in effect even if Greenland became independent in the future, that it bans non-NATO states from maintaining a military presence in Greenland; bars investments in Greenland by Russia and China, and grants the US permanent rights to install military bases and use Greenland's airspace. US Secretary of State Marco Rubio said that the deal "permanently and completely addresses our national security concerns in Greenland" and described it as a "huge win for the United States and the American people." Danish Prime Minister Mette Frederiksen said the deal strengthens "security in the Arctic and the North Atlantic area" and that the deal would be signed at the upcoming United Nations General Assembly. She did not discuss specific policies and stressed that it required parliamentary approval to be enacted.
== Research == One drug in test seemed to prevent the type of muscle loss that occurs in immobile, bedridden patients. Testing on mice showed that it blocked the activity of a protein present in the muscle that is involved in muscle atrophy. However, the drug's long-term effect on the heart precludes its routine use in humans, and other drugs are being sought.
where A = 0.02939 mPa·s, B = 507.88 K, and C = 149.3 K. Experimentally determined values of the viscosity are also given in the table below. The values at 20 °C are a useful reference: there, the dynamic viscosity is about 1 cP and the kinematic viscosity is about 1 cSt.
== Scientists and inventors == Samuel Bard* (1763), personal physician to George Washington; founder of the Columbia University College of Physicians and Surgeons John Stevens (King's 1768), builder of the first oceangoing steamboat in the U.S. Nicholas Romayne* (1774), physician, president of the Columbia University College of Physicians and Surgeons David Hosack (1790), physician, botanist, educator John Eatton Le Conte (1800), naturalist Samuel Akerly (1804), physician, co-founder of the New York Institute for the Education of the Blind Valentine Mott (1806), surgeon pioneer James Renwick (1807), English-American scientist and engineer, professor of Natural philosophy at Columbia University; father of architect James Renwick Jr. John Brodhead Beck (1813), New York physician Daniel Levy Maduro Peixotto (1816), Dutch-born Jewish American physician, former president of the Willoughby Medical College Henry James Anderson (1818), scientist and educator who participated in the U.S. Dead Sea exploration expedition Alfred Charles Post (1822), surgeon, professor at New York University School of MedicineS Horatio Allen (1823), imported the Stourbridge Lion, first successful steam locomotive to run in the U.S. John Clarkson Jay (1827), physician and notable conchologist, grandson of John Jay Alfred W. Craven (1829), chief engineering of Croton Aqueduct; founding member of the American Society of Civil Engineers Edward S.
=== Test to Stay === SHIELD Illinois piloted the "Test to Stay" program developed in cooperation with the Illinois Department of Public Health. Later endorsed by the CDC, Test to Stay allows unvaccinated students, faculty, and staff who have been exposed to SARS-CoV-2 positive individuals to remain in the classroom providing they wear a mask and test on days one, three, five, and seven following exposure. This program prevented the need to quarantine and exclude entire classes when one student in the group tests positive. During the pilot period alone, which only covered a population of 1,035 students and staff, "8,152 learning days were saved among close contacts."
Sources: en.wikipedia.org
Jay Johnson, previously head coach of the University of Nevada baseball program, succeeded Andy Lopez who retired after the 2015 season. In his first season as head coach, Johnson guided his team to the programs 17th College World Series appearance and 8th championship series appearance. Johnson resigned from the Wildcat program in June 2021 to accept the head coaching job at LSU. This was after leading the Wildcats to a Pac-12 conference championship and the 18th College World Series appearance in program history; they were eliminated in Omaha by Stanford. In July 2021, Chip Hale was named the new head coach of Arizona baseball. Hale played for the Wildcats under Jerry Kindall and was on the 1986 College World Series championship team; he went on to play, coach and manage in the major leagues for several years, serving as manager of the Arizona Diamondbacks in 2015 and 2016, and most recently serving as the third base coach of the Detroit Tigers. Arizona baseball also has a student section named The Hot Corner. Seventy-five former Arizona baseball players have played in the Major Leagues. Famous alums include Terry Francona, Kenny Lofton, Shelley Duncan, Trevor Hoffman, Mark Melancon, Chip Hale, Craig Lefferts, J. T. Snow, Don Lee, Carl Thomas, Jack Howell, Mike Paul, Dan Schneider, Rich Hinton, Ed Vosberg, Hank Leiber, Ron Hassey, Brad Mills, Joe Magrane, Alex Mejia, Dave Baldwin, Brian Anderson, Jack Daugherty, Scott Erickson, Gil Heredia, Casey Candaele, George Arias, and Scott Kingery.
acetoacetate + NADH + H+ The first step in the reaction is the substrate binding and this occurs by the carboxylate group of the substrate binding to the carboxylate group of the acetate part of the enzyme. Then the C3 atom from the substrate will form a hydrogen bond with the C4 atom of NAD+. Then when the reaction is occurring at the optimum pH a proton is removed from the hydroxyl group of the substrate and this allows for a carbonyl-bond to form. Simultaneously, the negative hydrogen ion on the C3 atom of the enzyme is transferred to the C4 atom on NAD+ and thus forming acetoacetate and NADH.
There are numerous associations and correlations in the body of evidence, but few causal relationships, since existing longitudinal datasets "do not use consistent wellbeing and predictor measures at different time points"; After controlling for mental health status, not many of the found associations are still significant; Subgroup analyses are rare; There are too few studies to conduct meta-analyses; There are too few interventional studies.
== See also == Advanced Landing Ground – a type of semi-permanent bases in Kent, France, Belgium, Netherlands and occupied Germany Air Ministry Experimental Station Chain Home – radar defence system developed during the Second World War Class A airfield – airfields constructed to Air Ministry specifications during the Second World War List of Battle of Britain airfields List of North African airfields during World War II List of Royal Air Force stations, current MoD and RAF stations List of Royal Air Force Satellite Landing Grounds List of V Bomber dispersal bases
The character of GLaDOS, voiced by Ellen McLain, received acclaim for her unique characterization and the end credits song "Still Alive", written by Jonathan Coulton, was praised for its original composition and humor. Portal is often cited as one of the greatest video games ever made. Excluding Steam download sales, over four million copies have been sold, spawning merchandise from Valve including a model portal gun and plush Companion Cubes, as well as fan recreations of the cake. A standalone version with extra puzzles, Portal: Still Alive, containing many recreated levels from a fan-made flash game, was published by Valve on the Xbox Live Arcade service in October 2008 for Xbox 360. A sequel, Portal 2, was released in 2011, which expanded on the storyline, added several gameplay mechanics, and included a cooperative multiplayer mode and level creator. A port for the Nintendo Switch was released as part of the Portal: Companion Collection in June 2022, which included the additional levels from the Still Alive release of the game. On December 8, 2022, a free remaster developed by Nvidia's Lightspeed Studios with Valve's permission was published on Steam under the name Portal with RTX in order to showcase Nvidia's RTX Remix tool.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue natural peptide, while TB-500 is a commercial label applied to a short synthetic fragment of it. The two differ in length, sequence coverage and how they are handled in the laboratory.
Published work usually examines actin binding, cell migration and tissue repair endpoints in cell and animal models. Findings are generally described as preliminary, and controlled human data remain limited.
Because TB-500 is a trade name rather than a chemical identifier, different vendors and papers may attach it to different fragment lengths. Checking the stated sequence is the practical way to resolve the ambiguity.
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.